Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **midbrain** (also called the **mesencephalon**) is a region of the brainstem, located between the forebrain and the hindbrain. It is not a single molecular entity, receptor, enzyme, transporter, or druggable protein, but an anatomical structure composed of multiple nuclei, fiber tracts, and subdivisions such as the tectum, tegmentum, and cerebral peduncles[1][2][3][4]. Key functions of the midbrain include coordination of eye movement, control of body and head movements, processing of visual and auditory signals, mediation of reflexive responses to sensory input, regulation of alertness and arousal (reticular formation), and participation in pain suppression (periaqueductal gray)[1][2][4][6]. Prominent midbrain structures include the superior and inferior colliculi (processing visual and auditory information, respectively), substantia nigra (source of dopamine involved in movement coordination; degeneration is central to Parkinson’s disease), red nucleus (movement coordination), and periaqueductal gray (modulation of pain and defensive behaviors)[1][2][4]. Damage or disease in the midbrain can contribute to movement disorders (such as Parkinson’s), certain congenital brain malformations, and impairments in vision, hearing, or reflexive responses[4][6]. As an anatomical brain region rather than a molecular target, the midbrain does not have known direct drug interactions or mechanisms of action akin to receptors or enzymes. Caveats: - The midbrain is a brain region, **not** a therapeutic target such as a receptor, enzyme, ion channel, or transporter. Marking as "is_incorrect: true" since it cannot be mapped onto the requested target-based classification scheme. - Many specific molecular targets (receptors, enzymes, etc.) are located within the midbrain, but "midbrain" itself is not druggable. If you are seeking information on a specific molecular target within the midbrain (e.g., "dopamine receptor D2" or "substantia nigra dopamine transporter"), please specify to return structured data for that molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Midbrain.